Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Housecall Pro unveils most-requested platform upgrades, turning feedback into action
-
Moody’s Corporation to Present at the Raymond James Annual Institutional Investors Conference on March 3, 2026
-
Mobilicom to Participate at Enforce Tac 2026, Germany’s Prominent Trade Fair for Security and Defense
-
New research shows top OEMs cut downtime recovery by 40%, strengthening profitability through resilience-first strategies
-
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
-
Abcuro Announces Topline Results from the MUSCLE Study of Ulviprubart in Patients with Inclusion Body Myositis
-
Generation Mining Continues Strengthening its Management Team
-
Bio-Techne to Present at Upcoming Investor Conferences
-
TelevisaUnivision Announces Fourth Quarter and Full Year 2025 Results
-
908 Devices to Participate in Investor Conferences in March
-
St. Petersburg Partners With Flood Risk America to Deliver $1M Flood Protection Upgrade
-
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
-
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
-
Polaris Inc. to Present at The Raymond James Institutional Investors Conference
-
AMD and Meta Announce Expanded Strategic Partnership to Deploy 6 Gigawatts of AMD GPUs
-
Quantum XChange Advances EUCC Milestone and Enterprise Scalability with Latest Release of Phio TX
-
Cipher Digital Provides Fourth Quarter and Full Year 2025 Business Update
-
Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
-
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
-
OROCO COMMENCES PHASE 2 DRILLING
-
Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
-
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
Aspect Announces Aspect Intelligence™: Redefining How AI Powers Workforce Operations
-
Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates
-
Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
-
Shoals Technologies Group and ON.energy to Deploy Critical-Power Systems for Leading AI Data-Center Operator
-
Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
-
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
-
iBio to Participate in Upcoming Investor Conferences
-
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
-
Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026
-
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
-
Abaxx Exchange Completes First Physical Delivery Under Gold Singapore Futures Contract
-
OTC Markets Group Welcomes GR Silver Mining Ltd. to OTCQX
-
OTC Markets Group Welcomes Dryden Gold Corp. to OTCQX
-
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052
-
Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
-
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
-
Avalo Therapeutics to Participate in Upcoming Investor Conferences
-
OTC Markets Group Welcomes Nations Royalty Corp. to OTCQX
-
Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2025
-
Autolus Therapeutics to Participate in Upcoming Investor Conferences
-
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
-
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
-
Electrovaya Receives $10.5 Million P.O from Fortune 500 Customer
-
Indivior to Participate in Upcoming Investor Conferences
-
Digipower X Announces Uplisting to Cboe Canada
-
Full year Trading Update and Notice of Results
-
NOA Welcomes Site Visit by Salta's Secretary of Mining to Review Project Progress and 2026 Work Program
-
Kalo Gold Enhances Drill Targeting at Vatu Aurum With Rapid detectORE(TM) Gold Screening
